Yung Hao Lin
Directeur/Membre du Conseil chez TCI GENE INC.
Fortune : 2 M $ au 30/04/2024
Profil
Yung Hao Lin is currently the Director at TCI GENE, Inc. and has been the Vice President-Global Business Center & Deputy GM at TCI Co., Ltd.
since 2012.
He also holds the position of Vice President-Global Business Center at Shanghai Biotech Co., Ltd.
Mr. Lin has a Master's in Business Administration from National Taiwan University and Fudan University, and an undergraduate degree from National Chiayi University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
TCI CO., LTD.
0,38% | 30/09/2022 | 450 359 ( 0,38% ) | 2 M $ | 30/04/2024 |
Postes actifs de Yung Hao Lin
| Sociétés | Poste | Début |
|---|---|---|
| TCI CO., LTD. | Corporate Officer/Principal | 01/01/2012 |
| TCI GENE INC. | Directeur/Membre du Conseil | 30/11/2021 |
Shanghai Biotech Co., Ltd.
 Shanghai Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of TCI Co., Ltd., Shanghai Biotech Co., Ltd. is a company that manufactures pharmaceuticals and cosmetics. The company is based in Shanghai, China. | Corporate Officer/Principal | - |
Formation de Yung Hao Lin
| National Chiayi University | Undergraduate Degree |
| National Taiwan University | Masters Business Admin |
| Fudan University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| TCI CO., LTD. | Health Technology |
| TCI GENE INC. | Health Services |
| Entreprise privées | 1 |
|---|---|
Shanghai Biotech Co., Ltd.
Shanghai Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of TCI Co., Ltd., Shanghai Biotech Co., Ltd. is a company that manufactures pharmaceuticals and cosmetics. The company is based in Shanghai, China. | Health Technology |